Plecanatide, Nusinersen, and Obeticholic acid.
作者信息
Hussar Daniel A, Douglas Deborah K
出版信息
J Am Pharm Assoc (2003). 2017 May-Jun;57(3):416-418. doi: 10.1016/j.japh.2017.04.006.
PMID:28506401
Abstract
摘要
相似文献
1
Plecanatide, Nusinersen, and Obeticholic acid.普卡那肽、诺西那生钠和奥贝胆酸。
J Am Pharm Assoc (2003). 2017 May-Jun;57(3):416-418. doi: 10.1016/j.japh.2017.04.006.
2
Obeticholic acid (Ocaliva) for primary biliary cholangitis.用于原发性胆汁性胆管炎的奥贝胆酸（奥可安）
Med Lett Drugs Ther. 2017 Mar 27;59(1517):53-55.
3
Plecanatide (Trulance) for chronic idiopathic constipation.
Med Lett Drugs Ther. 2017 Apr 24;59(1519):66-68.
4
Plecanatide for the treatment of chronic idiopathic constipation in adult patients.普卡必利治疗成人慢性特发性便秘。
Expert Rev Clin Pharmacol. 2019 Nov;12(11):1019-1026. doi: 10.1080/17512433.2019.1670057. Epub 2019 Oct 1.
5
Benefit-Risk Assessment of Plecanatide in the Treatment of Chronic Idiopathic Constipation.普卡那肽治疗慢性特发性便秘的获益-风险评估。
Drug Saf. 2019 May;42(5):603-615. doi: 10.1007/s40264-018-0781-9.
6
NAFLD: obeticholic acid for the treatment of fatty liver disease--NASH no more?非酒精性脂肪性肝病：奥贝胆酸用于治疗脂肪性肝病——非酒精性脂肪性肝炎不再适用了吗？
Nat Rev Gastroenterol Hepatol. 2015 Jan;12(1):1. doi: 10.1038/nrgastro.2014.203. Epub 2014 Nov 25.
7
Efficacy and safety of plecanatide in treating constipation predominant irritable bowel syndrome.普卡那肽治疗便秘型肠易激综合征的疗效与安全性。
Expert Opin Pharmacother. 2018 Feb;19(2):177-183. doi: 10.1080/14656566.2018.1427733. Epub 2018 Jan 29.
8
Liver Injury in Patients With Cholestatic Liver Disease Treated With Obeticholic Acid.接受奥贝胆酸治疗的胆汁淤积性肝病患者的肝损伤
Hepatology. 2020 Apr;71(4):1511-1514. doi: 10.1002/hep.31017. Epub 2020 Mar 24.
9
Nusinersen (Spinraza) for spinal muscular atrophy.用于脊髓性肌萎缩症的诺西那生（Spinraza）
Med Lett Drugs Ther. 2017 Mar 27;59(1517):50-52.
10
Guanylate cyclase C agonists: emerging gastrointestinal therapies and actions.鸟苷酸环化酶C激动剂：新兴的胃肠道治疗方法与作用
Gastroenterology. 2015 Mar;148(3):483-7. doi: 10.1053/j.gastro.2015.01.003. Epub 2015 Jan 7.
Zotero 插件